GSEP
ACET icon

Golden State Equity Partners’s Adicet Bio ACET Stock Holding History

Golden State Equity Partners’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,489
Closed -$57.9K – 336
2023
Q2 		$57.9K Hold
1,489
– – 0.02% 366
2023
Q1 		$137K Buy
+1,489
New +$187K 0.07% 207
2022
Q1 		$599K Buy
1,876
+1
+0.1% +$230 0.3% 97
2021
Q4 		$525K Buy
1,875
+43
+2% +$7.38K 0.27% 91
2021
Q3 		$230K Buy
1,832
+957
+109% +$119K 0.09% 205
2021
Q2 		$144K Buy
875
+53
+6% +$10.8K 0.06% 240
2021
Q1 		$172K Hold
822
– – 0.1% 163
2020
Q4 		$184K Buy
+822
New +$168K 0.13% 170

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Golden State Equity Partners's ACET Position: Q3 2023 in Review

Golden State Equity Partners sold out of Adicet Bio (ACET) in Q3 2023, closing a stake of 1,489 shares — an estimated $57.9K sold.

Golden State Equity Partners first reported a position in ACET in Q4 2020 and held it in 8 quarters. The position peaked at $599K in Q1 2022. 83 funds tracked by Wall St. Rank hold ACET as of Q3 2023.

  • Golden State Equity Partners reported no remaining Adicet Bio position as of Q3 2023 after selling out during the quarter.
  • Golden State Equity Partners sold 1,489 Adicet Bio shares in Q3 2023, an estimated $57.9K.
  • Golden State Equity Partners first reported a position in Adicet Bio in Q4 2020 and held it in 8 quarters.
  • Golden State Equity Partners's Adicet Bio position peaked at $599K in Q1 2022.
  • 83 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2023.

Based on Golden State Equity Partners's 13F filing for Q3 2023, filed 20 Oct 2023.